Abbott Biotech Ventures

Abbott Ventures functions as the corporate venture capital division of Abbott Laboratories, strategically investing in nascent companies across the biotechnology, pharmaceutical, medical device, and broader life sciences sectors. It provides capital and strategic support to innovators developing technologies that align with and can enhance Abbott’s expansive healthcare portfolio, focusing on areas with significant potential for medical advancement and market impact. This approach allows Abbott to engage with external innovation, complementing its internal research and development efforts.

The entity was established in 2004 by Abbott Laboratories, driven by the insight that actively investing in emerging enterprises could provide early access to disruptive technologies and novel therapeutic approaches. This proactive engagement allows Abbott to identify and nurture promising healthcare solutions from their foundational stages, fostering growth within the broader ecosystem while securing future opportunities for its core business.

Abbott Ventures primarily partners with early to growth-stage companies seeking both financial backing and the strategic advantages of an affiliation with a global healthcare leader. Its overarching vision is to accelerate the development and commercialization of groundbreaking healthcare solutions. By nurturing these innovative businesses, Abbott Ventures aims to improve patient outcomes and address unmet medical needs on a global scale, driving forward the future of health technology.